Outcomes and mortality risk scoring for infections caused by carbapenem-resistant Escherichia coli and Klebsiella pneumoniae
The Journal of Infection in Developing Countries · 2025
DOI: 10.3855/jidc.20725 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infection in Developing Countries, 2025. Verfasst von Jack El Sawda und 7 weiteren Autor:innen. Beteiligte Einrichtung: Washington University School of Medicine in St. Louis, St. Louis, MO, United States. Hauptthemen laut MEDLINE: Klebsiella pneumoniae, Klebsiella Infections, Carbapenem-Resistant Enterobacteriaceae, Anti-Bacterial Agents. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Carbapenem-resistant Enterobacterales (CRE) are becoming increasingly prevalent and have been associated with increased mortality. Due to the paucity of data from the region, we evaluated the risk factors and outcomes of infections caused by CRE at a tertiary care center in Lebanon. Methodology: The study had three arms in a case-case-control design: patients with CRE infections, patients with infections due to ceftriaxone-resistant carbapenem-susceptible Enterobacterales (CSE), and uninfected controls (UC). Logistic regression was performed to identify risk factors uniquely associated with CRE. A CRE infection score was also created to assess the likelihood of having a CRE infection.
Results
We included 337 patients (112 CRE, 75 CSE, 150 UC). Predictors unique to CRE infection included recent surgery (Odds Ratio (OR) 25.7; 95% confidence interval (CI95 5.7-115.2), carbapenem use within 30 days (OR 19.1; CI95 3.3-109.6), and malignancy (OR 4.2; CI95 1.6-10.5). The mean CRE score was 4.2 ± 2.2 in the CRE group and 2.4 ± 2.4 in the CSE group (p < 0.001). Infection-related mortality was higher among CRE patients (63.6% vs. 20.0%; p = 0.015), and CRE was independently associated with all-cause in-hospital mortality.
Conclusions
We developed a scoring system that would allow risk stratification and would guide empiric antibiotic therapy. CRE infections were associated with a worse outcome compared to CSE infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Washington University School of Medicine in St. Louis, St. Louis, MO, United States.
- Duke University, Durham, NC, United States.
- American University of Beirut, Beirut, Lebanon.
- Harvard Medical School, Boston, MA, United States.
- Memorial Sloan Kettering Cancer Center, New York, NY, United States.
- Mayo Clinic, Rochester, MN, United States.
Zitieren
APA
El Sawda, J., Abdulrahim, J., Mkahal, R. W., Doumat, G., Nawar, T., Saliba, A., Kanj, S. S., & Kanafani, Z. A. (2025). Outcomes and mortality risk scoring for infections caused by carbapenem-resistant Escherichia coli and Klebsiella pneumoniae. The Journal of Infection in Developing Countries. https://doi.org/10.3855/jidc.20725
Vancouver
El Sawda J, Abdulrahim J, Mkahal RW, Doumat G, Nawar T, Saliba A, et al. Outcomes and mortality risk scoring for infections caused by carbapenem-resistant Escherichia coli and Klebsiella pneumoniae. The Journal of Infection in Developing Countries. 2025. doi:10.3855/jidc.20725
BibTeX
@article{ElSawda2025,
author = {El Sawda, Jack and Abdulrahim, Jawan and Mkahal, Rayyan Wazzi and Doumat, George and Nawar, Tamara and Saliba, Antoine and Kanj, Souha S and Kanafani, Zeina A},
title = {Outcomes and mortality risk scoring for infections caused by carbapenem-resistant Escherichia coli and Klebsiella pneumoniae},
journal = {The Journal of Infection in Developing Countries},
year = {2025},
doi = {10.3855/jidc.20725}
}
EUVIMED